STAB2
Basic information
Region (hg38): 12:103587273-103766719
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the STAB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | |||||
missense | 158 | 15 | 182 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 4 | 7 | 11 | |||
non coding | 3 | |||||
Total | 0 | 0 | 158 | 25 | 20 |
Variants in STAB2
This is a list of pathogenic ClinVar variants found in the STAB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-103587480-A-G | not specified | Uncertain significance (Dec 12, 2023) | ||
12-103587510-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
12-103587525-A-G | not specified | Uncertain significance (Jun 11, 2024) | ||
12-103590914-G-T | not specified | Uncertain significance (Apr 26, 2023) | ||
12-103590955-C-T | not specified | Uncertain significance (Jun 01, 2022) | ||
12-103590976-G-T | not specified | Uncertain significance (Dec 21, 2023) | ||
12-103591006-G-T | not specified | Uncertain significance (Nov 16, 2022) | ||
12-103594442-G-A | not specified | Uncertain significance (Nov 01, 2021) | ||
12-103594474-C-T | not specified | Uncertain significance (Feb 06, 2023) | ||
12-103594475-G-A | not specified | Likely benign (Sep 06, 2022) | ||
12-103594489-C-T | not specified | Uncertain significance (Nov 08, 2022) | ||
12-103594490-G-A | not specified | Likely benign (Oct 04, 2022) | ||
12-103594490-G-T | not specified | Uncertain significance (Apr 09, 2024) | ||
12-103622081-G-A | not specified | Uncertain significance (Sep 29, 2023) | ||
12-103631608-T-C | Benign (Sep 11, 2018) | |||
12-103631642-G-A | Benign (Sep 11, 2018) | |||
12-103631668-G-A | Benign (Dec 31, 2019) | |||
12-103631675-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
12-103637165-C-T | not specified | Uncertain significance (Apr 19, 2024) | ||
12-103637216-G-A | not specified | Uncertain significance (Nov 14, 2023) | ||
12-103637218-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
12-103637219-A-G | not specified | Uncertain significance (May 29, 2024) | ||
12-103637245-A-C | Benign (Dec 04, 2017) | |||
12-103638039-A-G | not specified | Likely benign (Mar 25, 2024) | ||
12-103638061-G-T | not specified | Uncertain significance (Jul 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
STAB2 | protein_coding | protein_coding | ENST00000388887 | 69 | 179455 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.23e-62 | 0.00231 | 125286 | 0 | 462 | 125748 | 0.00184 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.157 | 1460 | 1.44e+3 | 1.01 | 0.0000802 | 16711 |
Missense in Polyphen | 476 | 514.34 | 0.92545 | 5921 | ||
Synonymous | -0.286 | 578 | 569 | 1.02 | 0.0000350 | 4828 |
Loss of Function | 2.80 | 116 | 154 | 0.756 | 0.00000839 | 1775 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00312 | 0.00312 |
Ashkenazi Jewish | 0.000415 | 0.000397 |
East Asian | 0.00225 | 0.00223 |
Finnish | 0.00148 | 0.00148 |
European (Non-Finnish) | 0.00178 | 0.00173 |
Middle Eastern | 0.00225 | 0.00223 |
South Asian | 0.00336 | 0.00317 |
Other | 0.00265 | 0.00245 |
dbNSFP
Source:
- Function
- FUNCTION: Phosphatidylserine receptor that enhances the engulfment of apoptotic cells. Hyaluronan receptor that binds to and mediates endocytosis of hyaluronic acid (HA). Acts also, in different species, as a primary systemic scavenger receptor for heparin (Hep), chondroitin sulfate (CS), dermatan sulfate (DS), nonglycosaminoglycan (GAG), acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides and advanced glycation end products (AGE). May serve to maintain tissue integrity by supporting extracellular matrix turnover or it may contribute to maintaining fluidity of bodily liquids by resorption of hyaluronan. Counter receptor which plays an important role in lymphocyte recruitment in the hepatic vasculature. Binds to both Gram-positive and Gram-negative bacteria and may play a role in defense against bacterial infection. The proteolytically processed 190 kDa form also functions as an endocytosis receptor for heparin internalisation as well as HA and CS. {ECO:0000269|PubMed:12077138, ECO:0000269|PubMed:12473645, ECO:0000269|PubMed:15208308, ECO:0000269|PubMed:15572036, ECO:0000269|PubMed:17145755, ECO:0000269|PubMed:17675564, ECO:0000269|PubMed:17962816, ECO:0000269|PubMed:18230608, ECO:0000269|PubMed:18434317, ECO:0000269|PubMed:18573870, ECO:0000269|PubMed:19359419}.;
- Pathway
- Vesicle-mediated transport;Hyaluronan uptake and degradation;Hyaluronan metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Metabolism;Scavenging by Class H Receptors;Binding and Uptake of Ligands by Scavenger Receptors
(Consensus)
Intolerance Scores
- loftool
- 0.0771
- rvis_EVS
- -2.68
- rvis_percentile_EVS
- 0.72
Haploinsufficiency Scores
- pHI
- 0.0815
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.654
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Stab2
- Phenotype
- renal/urinary system phenotype; neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- stab2
- Affected structure
- vascular lymphangioblast
- Phenotype tag
- abnormal
- Phenotype quality
- hypoplastic
Gene ontology
- Biological process
- angiogenesis;endocytosis;receptor-mediated endocytosis;cell adhesion;hyaluronan catabolic process;defense response to bacterium;defense response to Gram-positive bacterium;oxidation-reduction process
- Cellular component
- cytosol;plasma membrane;integral component of plasma membrane;external side of plasma membrane;endocytic vesicle membrane
- Molecular function
- low-density lipoprotein particle receptor activity;scavenger receptor activity;calcium ion binding;protein binding;hyaluronic acid binding;protein disulfide oxidoreductase activity;low-density lipoprotein particle binding